XML 33 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Summary of the activity in allowance for doubtful accounts

A summary of the activity in our allowance for doubtful accounts is as follows:

 

Years Ended   March 31, 2021   March 31, 2020
Balance, beginning of year   $ 58,000     $ 26,000  
Provision for (recoveries of) estimated losses     (16,322 )     32,168  
Write-off of uncollectible accounts     (6,678 )     (168 )
Balance, end of year   $ 35,000     $ 58,000  
Schedule of inventory

At March 31, 2021 and 2020, inventory consisted of the following:

 

    March 31, 2021   March 31, 2020
Raw materials   $ 1,038,094     $ 1,147,983  
Finished goods     477,040       516,918  
Total gross inventories     1,515,134       1,664,901  
Less reserve for obsolescence     (70,000 )     (39,000 )
Total net inventories   $ 1,445,134     $ 1,625,901  
Summary of the activity in inventory reserve for obsolescence

A summary of the activity in our inventory reserve for obsolescence is as follows:

 

Years Ended   March 31, 2021   March 31, 2020
Balance, beginning of year   $ 39,000     $ 50,000  
Provision for estimated obsolescence     31,528       (11,000 )
Write-off of obsolete inventory     (528 )     —    
Balance, end of year   $ 70,000     $ 39,000  
Summary of patents

A summary of our patents at March 31, 2021 and 2020 is as follows:

 

    March 31, 2021   March 31, 2020
Patents issued   $ 496,901     $ 473,607  
Accumulated amortization     (308,155 )     (281,649 )
Patents issued, net of accumulated amortization     188,746       191,958  
Patent applications     34,288       46,026  
Accumulated amortization     (9,666 )     (9,688 )
Patent applications, net of accumulated amortization     24,622       36,338  
Total net patents and patent applications   $ 213,368     $ 228,296  
Schedule of expected annual amortization expense related to patents and patent applications for the next five fiscal years

The expected annual amortization expense related to patents and patent applications as of March 31, 2021, for the next five fiscal years, is as follows:

 

Fiscal Year   Amount
  2022       24,705  
  2023       24,705  
  2024       21,787  
  2025       21,037  
  2026       20,220  
  Thereafter       100,914  
  Total     $ 213,368  
Schedule of other accrued liabilities

Other Accrued Liabilities. At March 31, 2021 and 2020, other accrued liabilities consisted of the following:

 

    March 31, 2021   March 31, 2020
Bonus   $ 95,795     $ 10,000  
Sales commissions     45,370       29,994  
Sales and use tax     15,065       12,037  
Marketing fees     15,330       10,511  
Payroll taxes     93,857       22,712  
Miscellaneous     16,685       10,823  
Total other accrued liabilities   $ 282,102     $ 96,077  
Schedule of stock-based compensation expense related to employee stock options

Stock-based compensation expense related to director and employee stock options under ASC 718 for fiscal years 2021 and 2020 was allocated as follows:

 

Years Ended   March 31, 2021   March 31, 2020
Cost of sales   $ 3,669     $ 2,811  
Sales and marketing     4,871       3,317  
General and administrative     22,632       22,671  
Research and development     2,182       1,909  
Stock-based compensation expense   $ 33,354     $ 30,708  
Schedule of service performs electrical engineering activities for external entities

Service performs electrical engineering activities for external entities.

 

    Year Ended March 31, 2021
   

 

Product

 

 

Service

 

 

Total

Net revenue   $ 7,010,657     $ 527,177     $ 7,537,834  
Cost of revenue     3,375,307       257,424       3,632,731  
Gross profit     3,635,350       269,753       3,905,103  
Operating income (loss)     (357,248 )     269,753       (61,641 )
Depreciation and amortization     88,955       —         88,955  
Capital expenditures     117,420       —         117,420  
Equipment and patents, net   $ 479,085     $ —       $ 479,085  
Schedule of calculation of basic and diluted net income (loss) per share

The following table presents the calculation of basic and diluted net income (loss) per share:

 

Years Ended   March 31, 2021   March 31, 2020
Net income (loss)   $ 584,734     $ (198,312 )
Weighted-average shares — basic     11,582,641       11,573,211  
Effect of dilutive potential common shares     185,356       —    
Weighted-average shares — basic and diluted     11,767,997       11,573,211  
Net loss per share — basic and diluted   $ 0.05     $ (0.02 )
Antidilutive equity units     850,644       998,000